Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.
Tsivgoulis G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, Heliopoulos I, Papathanasopoulos P, Dardiotis E, Kilidireas C, Voumvourakis K; HELANI (Hellenic Academy of Neuroimmunology). Tsivgoulis G, et al. Among authors: papathanasopoulos p. Ther Adv Neurol Disord. 2015 Sep;8(5):193-202. doi: 10.1177/1756285615600381. Ther Adv Neurol Disord. 2015. PMID: 26557896 Free PMC article.
The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Tsivgoulis G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, Heliopoulos I, Papathanasopoulos P, Kilidireas C, Voumvourakis K, Dardiotis E; HELANI (Hellenic Academy of Neuroimmunology). Tsivgoulis G, et al. Among authors: papathanasopoulos p. PLoS One. 2015 Dec 7;10(12):e0144538. doi: 10.1371/journal.pone.0144538. eCollection 2015. PLoS One. 2015. PMID: 26642051 Free PMC article. Review.
The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials.
Tsivgoulis G, Katsanos AH, Mavridis D, Grigoriadis N, Dardiotis E, Heliopoulos I, Papathanasopoulos P, Karapanayiotides T, Kilidireas C, Hadjigeorgiou GM, Voumvourakis K; HELANI (Hellenic Academy of Neuroimmunology). Tsivgoulis G, et al. Among authors: papathanasopoulos p. PLoS One. 2016 Sep 29;11(9):e0163296. doi: 10.1371/journal.pone.0163296. eCollection 2016. PLoS One. 2016. PMID: 27684943 Free PMC article.
Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial.
Messinis L, Nasios G, Kosmidis MH, Zampakis P, Malefaki S, Ntoskou K, Nousia A, Bakirtzis C, Grigoriadis N, Gourzis P, Papathanasopoulos P. Messinis L, et al. Among authors: papathanasopoulos p. Behav Neurol. 2017;2017:5919841. doi: 10.1155/2017/5919841. Epub 2017 Dec 31. Behav Neurol. 2017. PMID: 29463950 Free PMC article. Clinical Trial.
Commentary on: Comparing the efficacy of disease-modifying therapies in multiple sclerosis.
Tsivgoulis G, Katsanos AH, Voumvourakis K, Hadjigeorgiou GM, Heliopoulos I, Karapanayiotides T, Papathanasopoulos P, Kilidireas C, Grigoriadis N. Tsivgoulis G, et al. Among authors: papathanasopoulos p. Mult Scler Relat Disord. 2018 Apr;21:117-119. doi: 10.1016/j.msard.2018.03.010. Epub 2018 Mar 15. Mult Scler Relat Disord. 2018. PMID: 29724375 No abstract available.
Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis".
Tsivgoulis G, Palaiodimou L, Katsanos AH, Voumvourakis K, Hadjigeorgiou GM, Heliopoulos I, Karapanayiotides T, Papathanasopoulos P, Kilidireas C, Grigoriadis N. Tsivgoulis G, et al. Among authors: papathanasopoulos p. CNS Drugs. 2019 Mar;33(3):293-295. doi: 10.1007/s40263-019-00615-5. CNS Drugs. 2019. PMID: 30806966 No abstract available.
Do Secondary Progressive Multiple Sclerosis patients benefit from Computer- based cognitive neurorehabilitation? A randomized sham controlled trial.
Messinis L, Kosmidis MH, Nasios G, Konitsiotis S, Ntoskou A, Bakirtzis C, Grigoriadis N, Patrikelis P, Panagiotopoulos E, Gourzis P, Malefaki S, Papathanasopoulos P. Messinis L, et al. Among authors: papathanasopoulos p. Mult Scler Relat Disord. 2020 Jan 7;39:101932. doi: 10.1016/j.msard.2020.101932. Online ahead of print. Mult Scler Relat Disord. 2020. PMID: 31927200
102 results